1011 NW 15th Street, Miami, FL, 33136
Tanzania
Commentry
Amyloid Precursor Protein in Autism Spectrum Disorder
Author(s): Amadei C, Kow R and Nawaz ZAmadei C, Kow R and Nawaz Z
Amyloid precursor protein (APP) gets cleaved by α, β, and γ secretases in both amyloidogenic and nonamyloidogenic processing. In amyloidogenic processing, Aβ40 and Aβ42 peptides result, leading to amyloid plaques in the brain, associated with various dementias, especially Alzheimer’s disease. Amyloid plaques also occur in the brains of children with autism spectrum disorder (ASD), while both elevated and diminished levels of soluble APP have been found in the serum of ASD patients. Treatment with mGluR5 inhibitors has successfully lowered APP and Aβ levels in vitro as well as ASD symptoms in a mouse model. Differences in ASD genotype and phenotype along with similarities to neurodegenerative dementias must be considered when investigating new biomarkers and treatments for ASD... Read More»
DOI:
10.4172/1747-0862.1000342
Molecular and Genetic Medicine received 3919 citations as per Google Scholar report